We have not found any cost information for this lawyer
About Linda
Practice Areas
5
Practice Areas
Fees and Rates
Looking for an attorney? Avvo can help.
Search our directory
Quickly connect with top attorneys through our legal directory to get help with your legal issue.
Avvo's live chat agents can help coordinate a consultation with a local attorney.
Chat with a live agent who can match you with the right attorney for your legal needs.
Chat withLicenses
Licensed in Maryland for 50 years
State: Maryland
Acquired: 1975
No misconduct found
Licensed in District of Columbia for 49 years
State: District of Columbia
Acquired: 1976
No misconduct found
Location
Hogan & Hartson
1001 Pennsylvania Avenue Northwest, Washington, DC, 20004
Law Offices of Linda R Horton
5605 Griffith Farm Rd, Rockville, MD, 20855-1665
Ad
Transform legal challenges into solutions.
Connect now to review your situation.
Linda R Horton's Reviews
Avvo Review Score
Not Yet Reviewed
Linda R Horton's Lawyer Endorsements
No Endorsement Data Available Yet
This attorney hasn't received any attorney endorsements recently on Avvo.
No Endorsement Data Available Yet
This attorney hasn't created any attorney endorsements recently on Avvo.
Experience
Associations
Drug Information Association
Member
American Bar Association
Member
Education
1997
Georgetown University Law Center
LL.M - Master of Laws
1975
George Washington University National Law Center
JD - Juris Doctor
1968
University of Kentucky
BA - Bachelor of Arts
Publications
2007
Pharmaceutical & Biotechnology Update
UK Office of Fair Trading Market Study on the Pharmaceutical Price Regulation Scheme: Implications for Pricing Drugs in the UK
2006
Pharmaceutical and Biotechnology Update
The European Court of Justice Gives a Restrictive Interpretation of the SPC Regulation for Medicinal Product Patents: Will the MIT Judgment Affect Innovators' Research?
2006
Hogan & Hartson LLP
Regulation of Marketing Practices - Recent Trends
2006
Intellectual Property and Pharmaceutical & Biotechnology Update
A World Health Organization Commission Makes Recommendations for the Modification of Intellectual Property Rights in the Interest of Public Health
2006
Pharmaceuticals and Biotechnology Update
An EMEA Scientific Committee Issues a Positive Opinion on a Generic Version of a Centrally Authorized Pharmaceutical, Approved Just Eight Years Ago
2006
Pharmaceutical and Biotechnology Update
EU Moves Closer to a 'Biosimilar' Approval: What This Means for the EU and U.S. Markets